The deal setup
Bon Secours Mercy Health is negotiating to take control of Surgery Partners, according to the Financial Times. The sales process has been running for more than a year as backers sought a buyer.
Price, structure, and who stays in
Talks point to a valuation near $6 billion including $3.5 billion of debt, translating to approximately 20 dollars per share for Surgery Partners. Bain Capital, which backs the company, would remain a major shareholder with close to 40 percent if the transaction moves ahead.
Timeline and scale
An announcement could come as early as Monday. Bon Secours runs 47 hospitals and brought in about $14 billion of revenue last year, while Surgery Partners operates 176 facilities - surgery centers and hospitals - across 30 U.S. states.
When big healthcare deals are discussed, stay informed with the free Market Briefs newsletter in minutes each day.
What this means for your portfolio
If finalized, this would shift control of a multistate outpatient platform while leaving Bain with significant skin in the game. The bottom line: watch for confirmation on the near 6 billion dollar valuation, the 3.5 billion dollar debt component, and whether the nearly 40 percent Bain stake sticks, as those details will set the reference point for comps across hospital and ambulatory surgery center operators.
For anyone tracking corporate deals and strategy, sign up for the free Market Briefs for short daily market context.
